Sequential endocrine therapy and chemotherapy in metastatic breast cancer: effects on survival

Follow-up data of 113 patients with stage IV breast cancer treated with the antiestrogen tamoxifen show that the duration of remission is in average in excess of 21 months with a median of 16 months. Survival from start of antiestrogen therapy was significantly longer in patients who responded to ta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 1981-06, Vol.1 (2), p.97-103
Hauptverfasser:	Manni, A, Pearson, O H, Marshall, J S, Arafah, B M
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgens - administration & dosage Androgens - therapeutic use Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Breast Neoplasms - mortality Breast Neoplasms - therapy Drug Administration Schedule Drug Therapy, Combination Estrogen Antagonists - administration & dosage Estrogen Antagonists - therapeutic use Follow-Up Studies Humans Hypophysectomy Neoplasm Metastasis Palliative Care Tamoxifen - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!